BYDUREON 2 mg, poudre et solvant pour suspension injectable à libération prolongée en stylo prérempli — 4 stylo prérempli en verre avec aiguille(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400928012012
  • CIP7 2801201
  • CIS 66105532
  • Registration number EU/1/11/696

What the source publishes

Holder
ASTRAZENECA AB
Active ingredients
EXÉNATIDE
Form
poudre et solvant pour suspension injectable à libération prolongée
Package
4 stylo prérempli en verre avec aiguille(s)
Routes
sous-cutanée
Administrative status
cancelled
Supply regime
liste I
Marketing status
Déclaration d'arrêt de commercialisation
Authorised on
2014-10-01
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400928012012
{
  "cis": "66105532",
  "cip7": "2801201",
  "form": "poudre et  solvant pour suspension injectable à libération prolongée",
  "name": "BYDUREON 2 mg, poudre et solvant pour suspension injectable à libération prolongée en stylo prérempli — 4 stylo prérempli en verre avec aiguille(s)",
  "cip13": "3400928012012",
  "holder": "ASTRAZENECA AB",
  "routes": [
    "sous-cutanée"
  ],
  "holders": [
    "ASTRAZENECA AB"
  ],
  "currency": "EUR",
  "marketed": false,
  "bdmStatus": "Warning disponibilité",
  "useDomain": "unknown",
  "publicPrice": "77.60",
  "authorisedOn": "2014-10-01",
  "compositions": [
    {
      "name": "EXÉNATIDE",
      "nature": "SA",
      "strength": "2 mg",
      "linkageNumber": "1",
      "substanceCode": "93367",
      "dosageReference": "un stylo prérempli",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "liste I",
  "dispensingFee": "1.02",
  "medicinePrice": "76.58",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "BYDUREON 2 mg, poudre et solvant pour suspension injectable à libération prolongée en stylo prérempli",
  "marketingStatus": "Déclaration d'arrêt de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "non",
  "packageDescription": "4 stylo prérempli en verre avec aiguille(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2022-09-30",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "cancelled",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "EXÉNATIDE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation abrogée",
  "europeanAuthorisationNumber": "EU/1/11/696",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400928012012"